ObsEva SA, SWISS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch OBSEF and buy or sell other stocks, ETFs, and their options commission-free!

About OBSEF

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. 

CEO
Fabien de Ladonchamps
CEOFabien de Ladonchamps
Employees
15
Employees15
Headquarters
Geneva, Geneve (Geneva)
HeadquartersGeneva, Geneve (Geneva)
Founded
2012
Founded2012
Employees
15
Employees15

OBSEF Key Statistics

Market cap
11.72K
Market cap11.72K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.17K
Average volume1.17K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0501
52 Week high$0.0501
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

ObsEva SA, SWISS(OBSEF) stock is priced at $0.00, giving the company a market capitalization of 11.72K.

On 2026-07-26, ObsEva SA, SWISS(OBSEF) stock opened at —, reached a high of —, and a low of —.

ObsEva SA, SWISS(OBSEF) shares are trading with a volume of 0, against a daily average of 1.17K.

During the past year, ObsEva SA, SWISS(OBSEF) stock moved between $0.00 at its lowest and $0.05 at its peak.

During the past year, ObsEva SA, SWISS(OBSEF) stock moved between $0.00 at its lowest and $0.05 at its peak.

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.